Information Links
Mims
Main Navigation
Drugs
Conditions
News and resourcesNew drugs
New low-dose oestrogen gel for vaginal menopause symptoms
Blissel is a topical gel containing 50 microgram/g...
Further monthly injectable migraine prophylactic launched
With the launch of Emgality (galcanezumab), prescribers...
New non-oestrogen treatment for vaginal menopause symptoms
Intrarosa (prasterone) is a new topical treatment for...
New migraine prophylactic for monthly or quarterly injection
Fremanezumab (Ajovy) is a monoclonal antibody licensed...
Licensed melatonin treatment now available for children with autism
GPs can now prescribe melatonin as a licensed prolonged-release...
Second DPP4 inhibitor/SGLT2 inhibitor tablet launched for patients with diabetes
Prescribers can now consider Glyxambi (linagliptin/empagliflozin)...
New combination diabetes treatment launched
Suliqua is a titratable, fixed-ratio combination of...
Two new steroid inhalers launched
A new beclometasone metered-dose inhaler and a new...
NICE approves new diabetes treatment for NHS prescribing
Ertugliflozin (Steglatro), the newest sodium glucose...
New contraceptive vaginal ring launched
SyreniRing (ethinylestradiol/etonogestrel) is a contraceptive...
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
